Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 160,700
-6,500 (-3.89%)
Sep 11, 2026, 3:30 PM KST
Sam Chun Dang Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,761,580 | 5,407,457 | 3,453,735 | 1,759,153 | 966,580 | 956,650 | |
Market Cap Growth | -24.25% | 56.57% | 96.33% | 82.00% | 1.04% | -47.20% |
Enterprise Value | 3,809,387 | 5,448,908 | 3,434,172 | 1,814,629 | 1,017,570 | 978,256 |
Last Close Price | 160700.00 | 232500.00 | 148466.40 | 77182.01 | 43733.15 | 43283.83 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 210.78 | 1027.68 | - | - | 165.58 | - |
Forward PE | - | 111.99 | 111.99 | 111.99 | 111.99 | 111.99 |
PS Ratio | 14.47 | 23.33 | 16.37 | 9.13 | 5.45 | 5.72 |
PB Ratio | 9.39 | 14.87 | 9.89 | 5.89 | 3.94 | 3.82 |
P/TBV Ratio | 14.05 | 22.27 | 14.71 | 8.68 | 6.24 | 6.17 |
P/FCF Ratio | - | - | 727.36 | 105.58 | - | - |
P/OCF Ratio | 144.22 | 552.15 | 158.64 | 75.09 | 72.79 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 14.66 | 23.51 | 16.28 | 9.42 | 5.74 | 5.85 |
EV/EBITDA Ratio | 128.98 | 282.06 | 296.25 | 100.87 | 50.33 | - |
EV/EBIT Ratio | 215.16 | 654.51 | 1339.79 | 189.82 | 80.96 | - |
EV/FCF Ratio | - | - | 723.24 | 108.91 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.19 | 0.14 | 0.18 | 0.31 | 0.21 |
Debt / EBITDA Ratio | 1.76 | 3.61 | 4.31 | 2.98 | 3.79 | - |
Debt / FCF Ratio | - | - | 10.52 | 3.22 | - | - |
Net Debt / Equity Ratio | -0.13 | -0.16 | -0.26 | -0.13 | -0.04 | -0.20 |
Net Debt / EBITDA Ratio | -1.71 | -3.07 | -7.93 | -2.17 | -0.48 | 5.91 |
Net Debt / FCF Ratio | 1.65 | 1.63 | -19.37 | -2.35 | 2.97 | 2.24 |
Asset Turnover | 0.49 | 0.43 | 0.46 | 0.49 | 0.50 | 0.51 |
Inventory Turnover | 2.62 | 2.70 | 3.04 | 2.86 | 2.93 | 3.17 |
Quick Ratio | 1.61 | 1.73 | 2.15 | 2.21 | 3.27 | 2.53 |
Current Ratio | 2.21 | 2.27 | 2.60 | 2.83 | 4.13 | 3.13 |
Return on Equity (ROE) | 6.84% | 3.37% | -1.57% | -1.54% | 3.56% | -4.08% |
Return on Assets (ROA) | 2.08% | 0.96% | 0.34% | 1.53% | 2.19% | -2.89% |
Return on Invested Capital (ROIC) | 4.45% | 2.85% | -0.46% | 3.86% | 5.71% | -7.99% |
Return on Capital Employed (ROCE) | 3.80% | 1.80% | 0.60% | 2.70% | 3.80% | -5.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.47% | 0.10% | -0.32% | -0.59% | 0.60% | -1.73% |
FCF Yield | -0.81% | -0.67% | 0.14% | 0.95% | -0.34% | -2.36% |
Payout Ratio | 6.54% | 88.40% | - | - | 16.59% | - |
Buyback Yield / Dilution | -0.22% | -0.99% | -1.20% | -3.12% | - | -1.86% |